Table 2. Results from the validation study of miR-17, miR-21, and miR-145-expression in the normal-adenoma-adenocarcinoma sequence.

	Normal	Adenoma	Adenocarcinoma
miR-17
N	24	24	24
Low	24 (100%)	1 (4%)	1 (4%)
High	0	23 (96%)	23 (96%)
miR-21
N	24	24	22 a
Low	24 (100%)	7 (29%)	0
Moderate	0	16 (67%)	7 (32%)
High	0	1 (4%)	15 (68%)
miR-145
N	23 a	22 a	22 a
Low	0	11 (50%)	19 (86%)
High	23 (100%)	11 (50%)	3 (14%)

^aData missing due to specimens failing to include all three compartments.